A Rare Case Resistant Chemotherapy Thymoma B2 Type, New Approach

CASE REPORT
Vildana Goga Çmega, Arlinda Jakupi, Atdhe Agaj

 
International Journal of Biomedicine. 2023;13(4):380-384.
DOI: 10.21103/Article13(4)_CR5
Originally published December 5, 2023

Abstract: 

Invasive thymomas and thymic carcinomas are relatively rare tumors, which together represent about 0.2% to 1.5% of all malignancies. The majority of thymomas (90%) are found in the anterosuperior mediastinum. Type B2 thymoma, one of the rarest cases, was diagnosed in a 35-year-old male. Anamnesis, imaging examination, serological and invasive procedures confirmed the diagnosis. In 2020, the patient was operated on with thymoma R0-resection. The patient showed no progression until July 2022, when a locoregional recurrence was detected. The patient received 6 cycles of chemotherapy, to which the tumor showed resistance. After 6 months, the patient started a treatment with tyrosine kinase inhibitor sunitinib. If a patient is diagnosed with thymoma B2 that does not respond to standard chemotherapy, the tumor can be accepted as an aggressive one requiring a change to a new treatment.

Keywords: 
thymoma • diagnosis • treatment • outcome
References: 
  1. Mullen B, Richardson JD. Primary anterior mediastinal tumors in children and adults. Ann Thorac Surg. 1986 Sep;42(3):338-45. doi: 10.1016/s0003-4975(10)62751-8. 
  2. Nenninger R, Schultz A, Hoffacker V, Helmreich M, Wilisch A, Vandekerckhove B, Hünig T, Schalke B, Schneider C, Tzartos S, Kalbacher H, Müller-Hermelink HK, Marx A. Abnormal thymocyte development and generation of autoreactive T cells in mixed and cortical thymomas. Lab Invest. 1998 Jun;78(6):743-53. 
  3. Engels EA, Pfeiffer RM. Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer. 2003 Jul 1;105(4):546-51. doi: 10.1002/ijc.11099.
  4. Ströbel P, Bauer A, Puppe B, Kraushaar T, Krein A, Toyka K, Gold R, Semik M, Kiefer R, Nix W, Schalke B, Müller-Hermelink HK, Marx A. Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J Clin Oncol. 2004 Apr 15;22(8):1501-9. doi: 10.1200/JCO.2004.10.113.
  5. Kondo K, Monden Y. Thymoma and myasthenia gravis: a clinical study of 1,089 patients from Japan. Ann Thorac Surg. 2005 Jan;79(1):219-24. doi: 10.1016/j.athoracsur.2004.06.090.
  6. Batata MA, Martini N, Huvos AG, Aguilar RI, Beattie EJ Jr. Thymomas: clinicopathologic features, therapy, and prognosis. Cancer. 1974 Aug;34(2):389-96. doi: 10.1002/1097-0142(197408)34:2<389::aid-cncr2820340224>3.0.co;2-z.
  7. Bergh NP, Gatzinsky P, Larsson S, Lundin P, Ridell B. Tumors of the thymus and thymic region: I. Clinicopathological studies on thymomas. Ann Thorac Surg. 1978 Feb;25(2):91-8. doi: 10.1016/s0003-4975(10)63498-4. 
  8. Bernatz PE, Khonsari S, Harrison EG Jr, Taylor WF. Thymoma: factors influencing prognosis. Surg Clin North Am. 1973 Aug;53(4):885-92. doi: 10.1016/s0039-6109(16)40093-9.
  9. Curran WJ Jr, Kornstein MJ, Brooks JJ, Turrisi AT 3rd. Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol. 1988 Nov;6(11):1722-7. doi: 10.1200/JCO.1988.6.11.1722.
  10. Davis RD Jr, Oldham HN Jr, Sabiston DC Jr. Primary cysts and neoplasms of the mediastinum: recent changes in clinical presentation, methods of diagnosis, management, and results. Ann Thorac Surg. 1987 Sep;44(3):229-37. doi: 10.1016/s0003-4975(10)62059-0. 
  11. LEGG MA, BRADY WJ. PATHOLOGY AND CLINICAL BEHAVIOR OF THYMOMAS. A SURVEY OF 51 CASES. Cancer. 1965 Sep;18:1131-44. doi: 10.1002/1097-0142(196509)18:9<1131::aid-cncr2820180914>3.0.co;2-f. 
  12. LeGolvan DP, Abell MR. Thymomas. Cancer. 1977 May;39(5):2142-57. doi: 10.1002/1097-0142(197705)39:5<2142::aid-cncr2820390531>3.0.co;2-q. 
  13. Patterson GA. Thymomas. Semin Thorac Cardiovasc Surg. 1992 Jan;4(1):39-44.
  14. Marx A, Chan JK, Coindre JM, Detterbeck F, Girard N, Harris NL, Jaffe ES, Kurrer MO, Marom EM, Moreira AL, Mukai K, Orazi A, Ströbel P. The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes. J Thorac Oncol. 2015 Oct;10(10):1383-95. doi: 10.1097/JTO.0000000000000654.
  15. Suster S. Diagnosis of thymoma. J Clin Pathol. 2006 Dec;59(12):1238-44. doi: 10.1136/jcp.2005.031138. 
  16. Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg. 2003 Sep;76(3):878-84; discussion 884-5. doi: 10.1016/s0003-4975(03)00555-1. 
  17. Cowen D, Richaud P, Mornex F, Bachelot T, Jung GM, Mirabel X, Marchal C, Lagrange JL, Rambert P, Chaplain G, et al. Thymoma: results of a multicentric retrospective series of 149 non-metastatic irradiated patients and review of the literature. FNCLCC trialists. Fédération Nationale des Centres de Lutte Contre le Cancer. Radiother Oncol. 1995 Jan;34(1):9-16. doi: 10.1016/0167-8140(94)01493-m.
  18. Regnard JF, Fourquier P, Levasseur P. Results and prognostic factors in resections of primary tracheal tumors: a multicenter retrospective study. The French Society of Cardiovascular Surgery. J Thorac Cardiovasc Surg. 1996 Apr;111(4):808-13; discussion 813-4. doi: 10.1016/s0022-5223(96)70341-0.
  19. Amini A, Rusthoven CG. Thymoma: does tumor size matter? J Thorac Dis. 2019 Sep;11(Suppl 15):S2005-S2007. doi: 10.21037/jtd.2019.06.40.
  20. Bian D, Zhou F, Yang W, Zhang K, Chen L, Jiang G, Zhang P, Wu C, Fei K, Zhang L. Thymoma size significantly affects the survival, metastasis and effectiveness of adjuvant therapies: a population based study. Oncotarget. 2018 Jan 23;9(15):12273-12283. doi: 10.18632/oncotarget.24315. 
  21. Fukui T, Fukumoto K, Okasaka T, Kawaguchi K, Nakamura S, Hakiri S, Ozeki N, Hirakawa A, Tateyama H, Yokoi K. Prognostic impact of tumour size in completely resected thymic epithelial tumours. Eur J Cardiothorac Surg. 2016 Dec;50(6):1068-1074. doi: 10.1093/ejcts/ezw178. 
  22. Okumura M, Yoshino I, Yano M, Watanabe SI, Tsuboi M, Yoshida K, Date H, Yokoi K, Nakajima J, Toyooka SI, Asamura H, Miyaoka E. Tumour size determines both recurrence-free survival and disease-specific survival after surgical treatment for thymoma. Eur J Cardiothorac Surg. 2019 Jul 1;56(1):174-181. doi: 10.1093/ejcts/ezz001.
  23. Lewis JE, Wick MR, Scheithauer BW, Bernatz PE, Taylor WF. Thymoma. A clinicopathologic review. Cancer. 1987 Dec 1;60(11):2727-43. doi: 10.1002/1097-0142(19871201)60:11<2727::aid-cncr2820601125>3.0.co;2-d. 
  24. Maggi G, Casadio C, Cavallo A, Cianci R, Molinatti M, Ruffini E. Thymoma: results of 241 operated cases. Ann Thorac Surg. 1991 Jan;51(1):152-6. doi: 10.1016/0003-4975(91)90478-9. 
  25. Maggi G, Giaccone G, Donadio M, Ciuffreda L, Dalesio O, Leria G, Trifiletti G, Casadio C, Palestro G, Mancuso M, et al. Thymomas. A review of 169 cases, with particular reference to results of surgical treatment. Cancer. 1986 Aug 1;58(3):765-76. doi: 10.1002/1097-0142(19860801)58:3<765::aid-cncr2820580326>3.0.co;2-s. 
  26. Detterbeck FC, Parsons AM. Thymic tumors. Ann Thorac Surg. 2004 May;77(5):1860-9. doi: 10.1016/j.athoracsur.2003.10.001. 
  27. Blumberg D, Port JL, Weksler B, Delgado R, Rosai J, Bains MS, Ginsberg RJ, Martini N, McCormack PM, Rusch V, et al. Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg. 1995 Oct;60(4):908-13; discussion 914. doi: 10.1016/0003-4975(95)00669-c. 
  28. Lewis JE, Wick MR, Scheithauer BW, Bernatz PE, Taylor WF. Thymoma. A clinicopathologic review. Cancer. 1987 Dec 1;60(11):2727-43. doi: 10.1002/1097-0142(19871201)60:11<2727::aid-cncr2820601125>3.0.co;2-d. 

Download Article
Received August 24, 2023.
Accepted October 9, 2023.
©2023 International Medical Research and Development Corporation.